European CROMedical Devices Pharmaceuticals
Search: cerca
 
Home
 
 
DEVICE CLINICAL STUDIES
IN EUROPE AND THE US:
REGULATORY FRAMEWORK
AND BEST PRACTICES


Change of Date!


Wednesday 16 June 2010
ROME, ITALY


Click here for program details

print this page  

Medical Device EU/US Quality and Regulatory Services

Your partner from successful product launch to reaching your business objectives and beyond

US and European Device Regulatory

For over 20 years, a recognized resource for reliable and accurate US and European medical technology regulatory expertise, including combination products and ATMPs. Donawa Lifescience Consulting (DLC) also provides highly respected European Authorized Representative services.


Quality Systems

DLC is a recognized leader in US and European quality system development, implementation, assessment and compliance. Equally proficient with ISO 13485, 21 CFR 820 and PAL 169 quality systems.

 

Software Compliance

Compliance of medical device software with US and European regulatory requirements needs very specific expertise, which DLC has available to assist companies, from early development to market clearance.

 

Environmental Services

A new service for device companies, provided by our experienced Environmental Affairs Associate, helping companies meet the growing list of European environmental directives and standards.

 

Clinical Studies in Europe

Located throughout Europe, a full-service European CRO specializing in medical devices and conducting clinical studies that are valid for the US and elsewhere. Visit our dedicated CRO website further details.

 

The DLC Quality and Regulatory service is managed from our headquarters in the historical centre of Rome, Italy. Contact us either by e-mail for a confidential discussion about your project, or call Dr. Maria Donawa, President, on +39 06 578 2665.

FDA to hold meeting on addressing unmet public health needs. Click here.
FDA Transparency Task Force report published. Click here.

FDA issues draft guidance on submission of ISO 13485 audit reports. Click here.

GHTF publishes two final guidance documents. Click here.

No Evidence Linking Cell Phone Use to Risk of Brain Tumors, says FDA. Click here.

FDA to hold meeting on addressing unmet public health needs. Click here.
 

Copyright © 2006-2009  
Donawa Lifescience Consulting S.r.l. - All rights reserved. P.IVA/VAT N. IT10442731005